Activating transcription factor 4 (ATF4), encoded by the ATF4 gene, is a basic leucine zipper (bZIP) transcription factor that plays a key role in cellular stress adaptation. It is a central node of the integrated stress response (ISR), a conserved signaling network activated by a variety of cellular insults, such as endoplasmic reticulum (ER) stress (unfolded protein response - UPR), amino acid deprivation, oxidative stress, hypoxia, and viral infection. Once synthesized, ATF4 binds to specific DNA sequences (C/EBP-ATF response elements - CAREs) in the promoters of its target genes by homodimerization or heterodimerization with other bZIP proteins, such as members of the C/EBP family. Its transcriptional program is complex and context-dependent, promoting cell survival or apoptosis. Key target genes regulated by ATF4 include those involved in amino acid metabolism and transport (e.g., ASNS, CHOP), redox homeostasis (e.g., glutathione synthesis genes), autophagy, angiogenesis (e.g., VEGF), and ER chaperones. Thus, ATF4 plays a crucial role in a variety of physiological and pathological processes, including development, metabolism, neurodegeneration, cancer progression (it can support tumor survival and metastasis), and ischemia-reperfusion injury.
Human ATF4 adenoviral particles are complex recombinant viral vectors specifically engineered to deliver and overexpress the human ATF4 gene in a variety of mammalian cells, both dividing and non-dividing. These particles are typically based on human adenovirus serotype 5 (Ad5) and engineered to be replication-incompetent for improved safety. Researchers use them to study the consequences of ATF4 activation in a variety of cell models, mimicking certain aspects of the ISR without applying the potentially complex and pleiotropic primary stressors themselves. This allows us to precisely dissect ATF4''s downstream signaling pathways, target genes, and their specific contributions to cellular phenotypes such as survival, death, differentiation, metabolism, or adaptation to microenvironmental challenges (e.g., nutrient deprivation, hypoxia).
Ferroptosis is a regulated form of cell death characterized by lipid peroxidation and iron accumulation, and its role in disease pathogenesis is increasingly appreciated. The unfolded protein response (UPR) is associated with endoplasmic reticulum (ER) stress and ferroptosis-mediated cell fate decisions. However, the specific mechanisms remain unclear. In this study, researchers demonstrated that both tunicamycin-induced ER stress and erastin-triggered ferroptosis activate the UPR, thereby inducing ferroptosis. This cell death can be alleviated by the use of chemical chaperones and ferroptosis inhibitors. Among the three branches of the UPR, the PERK-eIF2α-ATF4 signaling axis was identified as a key mediator in this process. Mechanistically, ATF4-driven DDIT4 induction plays a key role, promoting ferroptosis by inhibiting the mTORC1 pathway. In addition, acetaminophen (APAP)-induced hepatotoxicity was studied as a model of eIF2α-ATF4-mediated ferroptosis. These findings suggest that inhibition of eIF2α-ATF4 or ferroptosis protects against APAP-induced liver injury, highlighting the therapeutic potential of targeting these pathways. Overall, this study not only elucidates the complex role of the PERK-eIF2α-ATF4 axis in ER stress and erastin-induced ferroptosis, but also extends these findings to clinically relevant models, laying the foundation for potential therapeutic interventions in diseases characterized by dysregulated ferroptosis and ER stress.
To investigate the role of ATF4 in ferroptosis, researchers used adenovirus to overexpress ATF4 (Ad-ATF4), which resulted in increased cell death and elevated Ptgs2 expression and lipid peroxidation levels after erastin treatment compared to control virus expressing GFP (Ad-GFP) (Figure 1F-H). Ad-ATF4 significantly altered the expression of ferroptosis-related proteins and MDA levels after erastin treatment compared to cells infected with Ad-GFP (Figure 1I). In subsequent experiments, ATF4 was reintroduced into Atf4−/− cells, which had previously shown resistance to erastin-induced ferroptosis. Unlike cells infected with Ad-GFP, Atf4−/− cells infected with Ad-ATF4 showed a marked increase in sensitivity to ferroptosis, comparable to Atf4+/+ cells (Figure 1J). These cells also showed enhanced responsiveness to the erastin-triggered ferroptosis pathway, exhibiting elevated Ptgs2 mRNA levels, increased lipid peroxidation, and altered GPX4, CHAC1, and DDIT4 protein expression and MDA levels after erastin treatment, similar to Atf4+/+ cells (Figure 1K-M). These results suggest that ATF4 is involved in the activation of ferroptosis signaling and may potentially contribute to ferroptosis-mediated cell death.
Figure 1. ATF4 is an important transcription factor for erastin-induced ferroptotic pathway. (Nghiem T H T, et al., 2025)
Customer Reviews
Consistent Results
We used the Human ATF4 adenoviral particles to study ER stress responses, and the results were consistently robust. The particles were pure, with no detectable contaminants, and customer support was prompt with technical advice. A+!
United Kingdom
11/07/2023
Write a Review